Small molecule inhibitors of Bcl-2 function: Modulators of apoptosis and promising anticancer agents

Current Opinion in Drug Discovery and Development

Volumn 3, Issue 5, 2000, Pages 565-574

  Huang, Z ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Apoptosis; Bcl 2; Bcl 2 inhibitor; BH3 peptide; Cancer; Caspase; Chemoresistance; Drug design; Mitochondria; Natural products

Indexed keywords

ANTIMYCIN A1; ANTINEOPLASTIC AGENT; CASPASE; HA 14 1; NATURAL PRODUCT; PEPTIDE; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN INHIBITOR; TETROCARCIN A; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER; DRUG DESIGN; DRUG SCREENING; MITOCHONDRION; MOLECULAR MIMICRY; MOLECULAR RECOGNITION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0033778458     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Apoptosis in the pathogenesis and treatment of disease
2. Death receptors: Signaling and modulation
3. Mitochondria and apoptosis
4. The Bcl-2 protein family: Arbiters of cell survival
5. Bcl-2 family: Regulators of cell death
6. Bcl-2 and the regulation of programmed cell death
7. BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
8. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
9. Bcl-2 antisense therapy in patients with non-Hodgkin lymphoma
10. X-ray and NMR structure of human Bcl-x(L), an inhibitor of programmed cell death
11. Crystal structure of rat Bcl-x(L). Implications for the function of the Bcl-2 protein family
12. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
13. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions
14. Blk, a novel death-inducing protein shares s distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins
15. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2
16. Structure of Bcl-x(L)-Bak peptide complex: Recognition between regulators of apoptosis
17. Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists
18. Solution structure of BID, an intracellular amplifier of apoptotic signaling
19. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
20. Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7
21. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-x(L)
22. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant Bcl-2 and Bcl-x(L) proteins
23. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members
24. Regulation of apoptosis by BH3 domains in a cell-free system
25. Bax directly induces release of cytochrome c from isolated mitochondria
26. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
27. Peptides which mimic the BH3 domain of pro-apoptotic products of the bcl-2 gene family induce apoptosis in prostate carcinoma cells
28. Bak BH3 peptides antagonize Bcl-x(L) function and induce apoptosis through cytochrome c-independent activation of caspases
29. Cell permeable Bcl-2 binding peptides: A chemical approach to apotosis induction in tumor cells
30. Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its antiapoptotic activity
31. Novel antitumor antibiotics, tetrocarcins
32. Antimycin A mimics a BH3 domain-containing peptide and selectively induces apoptosis in cell lines overexpressing Bcl-x(L)
33. Isolation, structure and properties of antimycin A
34. Structural factors of antimycin A molecule required for inhibitory action
35. Structural chemistry and therapeutic intervention of protein-protein interaction in immune response, human immunodeficiency virus entry and apoptosis
36. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
37. Reactions of salicylaldehydes with alkyl cyanoacetetes on the surface of solid catalysts: Synthesis of 4H-chromene derivatives